Emerging Treatment with EPT Fumarate for Mitochondrial Dysfunction
Mitochondrial dysfunction plays a wide range of chronic diseases. This deficiency in mitochondrial function can lead to cellular stress, ultimately resulting in various pathologies. EPT Fumarate, a novel therapeutic agent, has emerged as a promising treatment for addressing this debilitating condition. EPT Fumarate acts by activating the activity